Charles Weston
Stock Analyst at RBC Capital
(0.14)
# 4,465
Out of 4,574 analysts
340
Total ratings
34.6%
Success rate
-7.1%
Average return
Main Sectors:
Stocks Rated by Charles Weston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Hold | €220.00 | €221.00 | -0.45% | 22 | Jul 23, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Buy | €210.00 | €167.30 | +25.52% | 21 | Jul 23, 2026 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | CHF 720.00 → CHF 760.00 | CHF 548.00 | +38.69% | 39 | Jul 23, 2026 | |
| ETR: EVT Evotec SE | Maintained: Buy | €10.00 | €3.45 | +189.52% | 53 | Jul 14, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Upgraded: Buy | €18.00 → €21.00 | €21.00 | - | 8 | Jul 9, 2026 | |
| SWX: PPGN PolyPeptide Group AG | Downgraded: Hold | CHF 44.00 | CHF 43.75 | +0.57% | 9 | Jul 7, 2026 | |
| LON: SN Smith & Nephew plc | Maintained: Hold | 1,350p | 1,140p | +18.42% | 1 | Jun 29, 2026 | |
| LON: OXB Oxford Biomedica plc | Reiterated: Buy | 1,170p → 1,140p | 571p | +99.65% | 29 | Jun 24, 2026 | |
| AIM: 4BB 4basebio PLC | Maintained: Buy | 1,600p → 1,400p | 525p | +166.67% | 4 | Jun 15, 2026 | |
| SWX: BANB Bachem Holding AG | Maintained: Buy | CHF 110.00 | CHF 75.05 | +46.57% | 11 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 225p | 108p | +108.72% | 31 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €32.00 | €27.80 | +15.11% | 1 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 108.00 → CHF 96.00 | CHF 70.70 | +35.79% | 16 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 1,900p | 1,196p | +58.86% | 23 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 480p → 410p | 383p | +7.04% | 21 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $67.09 | - | 1 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $284 | $106.00 | n/a | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 310p | 224p | n/a | 20 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 215p | 216p | n/a | 14 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 26.00 | CHF 3.18 | n/a | 4 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 287.00 | kr 39.42 | n/a | 2 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 160p | 66p | n/a | 1 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6.94 | $0.41 | n/a | 8 | Apr 24, 2018 |
Sartorius Aktiengesellschaft
Jul 23, 2026
Maintained: Hold
Price Target: €220.00
Current: €221.00
Upside: -0.45%
Sartorius Stedim Biotech S.A.
Jul 23, 2026
Maintained: Buy
Price Target: €210.00
Current: €167.30
Upside: +25.52%
Lonza Group AG
Jul 23, 2026
Maintained: Buy
Price Target: CHF 720.00 → CHF 760.00
Current: CHF 548.00
Upside: +38.69%
Evotec SE
Jul 14, 2026
Maintained: Buy
Price Target: €10.00
Current: €3.45
Upside: +189.52%
SCHOTT Pharma AG & Co. KGaA
Jul 9, 2026
Upgraded: Buy
Price Target: €18.00 → €21.00
Current: €21.00
Upside: -
PolyPeptide Group AG
Jul 7, 2026
Downgraded: Hold
Price Target: CHF 44.00
Current: CHF 43.75
Upside: +0.57%
Smith & Nephew plc
Jun 29, 2026
Maintained: Hold
Price Target: 1,350p
Current: 1,140p
Upside: +18.42%
Oxford Biomedica plc
Jun 24, 2026
Reiterated: Buy
Price Target: 1,170p → 1,140p
Current: 571p
Upside: +99.65%
4basebio PLC
Jun 15, 2026
Maintained: Buy
Price Target: 1,600p → 1,400p
Current: 525p
Upside: +166.67%
Bachem Holding AG
Jun 9, 2026
Maintained: Buy
Price Target: CHF 110.00
Current: CHF 75.05
Upside: +46.57%
May 26, 2026
Reiterated: Buy
Price Target: 225p
Current: 108p
Upside: +108.72%
May 12, 2026
Maintained: Hold
Price Target: €32.00
Current: €27.80
Upside: +15.11%
Mar 16, 2026
Maintained: Hold
Price Target: CHF 108.00 → CHF 96.00
Current: CHF 70.70
Upside: +35.79%
Mar 4, 2026
Maintained: Buy
Price Target: 1,900p
Current: 1,196p
Upside: +58.86%
Feb 24, 2026
Maintained: Buy
Price Target: 480p → 410p
Current: 383p
Upside: +7.04%
Feb 11, 2026
Upgraded: Buy
Price Target: n/a
Current: $67.09
Upside: -
Jan 7, 2025
Reiterated: Buy
Price Target: $284
Current: $106.00
Upside: n/a
Nov 19, 2024
Maintained: Buy
Price Target: 310p
Current: 224p
Upside: n/a
Mar 23, 2023
Maintained: Hold
Price Target: 215p
Current: 216p
Upside: n/a
Jul 12, 2021
Maintained: Buy
Price Target: CHF 26.00
Current: CHF 3.18
Upside: n/a
Apr 13, 2021
Maintained: Buy
Price Target: kr 287.00
Current: kr 39.42
Upside: n/a
Nov 2, 2018
Maintained: Buy
Price Target: 160p
Current: 66p
Upside: n/a
Apr 24, 2018
Maintained: Buy
Price Target: $6.94
Current: $0.41
Upside: n/a